IXJiShares Global Healthcare ETF


$ 96.11 $ 0.66 (0.69 %)    

Friday, 09-Aug-2024 15:48:22 EDT
QQQ $ 450.22 $ 2.34 (0.52 %)
DIA $ 395.16 $ 0.63 (0.16 %)
SPY $ 532.81 $ 2.34 (0.44 %)
TLT $ 96.28 $ 0.94 (0.99 %)
GLD $ 224.54 $ 0.55 (0.25 %)
$ 96.22
$ 96.10 x 100
-- x --
-- - --
$ 76.90 - $ 96.73
88,488
na
na
$ 0.72
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 upward-trajectory-for-biotechpharma-ma-sector-trends-towards-pre-pandemic-levels-forecasts-positive-for-2024

According to the Global Data report, the pharma sector in Q3 2023 witnessed deals worth $28 billion, down 28% from the $54 bill...

 next-stop-recession-industries-that-benefit-in-an-economic-downturn--etfs-to-consider

A recession is a significant decline in economic activity that lasts for a sustained period of time. More specifically, a reces...

 us-supports-delay-on-covid-patent-waiver-extension-decision

Developing countries have been pushing for a patent waiver extension for COVID-19, which many developed countries argue could...

 why-who-did-not-recommend-convalescent-plasma-therapy-for-covid-19

The World Health Organization said that it's not recommending the use of convalescent plasma as a treatment for COVID-19 fo...

 new-drug-applications-pile-up-with-fda-as-pandemic-still-sore-spot-for-delayed-inspections

The FDA continues to face a backlog of drug manufacturing facility inspections.

 uk-rolls-out-covid-19-antibody-tests-for-all-what-you-need-to-know

On Sunday, the U.K. government rolled out a new nationwide antibody surveillance program, in which anyone over 18 years can o...

Core News & Articles

On CNBC's "Fast Money Halftime Report," Jim Lebenthal revealed that he is bullish on Walt Disney Co (NYSE: DIS).

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION